Mascoma Wealth Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.44K Hold
100
﹤0.01% 371
2026
Q1
$4.29K Hold
100
﹤0.01% 376
2025
Q4
$4.38K Hold
100
﹤0.01% 376
2025
Q3
$4.13K Hold
100
﹤0.01% 389
2025
Q2
$4.41K Hold
100
﹤0.01% 390
2025
Q1
$3.69K Buy
+100
New +$3.56K ﹤0.01% 425
2018
Q3
Sell
-1,000
Closed -$22K 399
2018
Q2
$22K Hold
1,000
0.02% 214
2018
Q1
$22K Hold
1,000
0.01% 212
2017
Q4
$30K Hold
1,000
0.02% 176
2017
Q3
$24K Hold
1,000
0.02% 208
2017
Q2
$25K Hold
1,000
0.02% 214
2017
Q1
$22K Hold
1,000
0.02% 208
2016
Q4
$15K Buy
+1,000
New +$14.4K 0.01% 237

Other funds holding EXEL

Mascoma Wealth Management's EXEL Position: Q2 2026 in Review

Mascoma Wealth Management held its Exelixis (EXEL) position steady in Q2 2026 at 100 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Mascoma Wealth Management first reported a position in EXEL in Q4 2016 and has held it in 13 quarters since. The position peaked at $30K in Q4 2017. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Mascoma Wealth Management held 100 shares of Exelixis worth $5.44K as of Q2 2026.
  • Mascoma Wealth Management left its Exelixis share count unchanged in Q2 2026.
  • Exelixis made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #371 holding.
  • Mascoma Wealth Management first reported a position in Exelixis in Q4 2016 and has held it in 13 quarters since.
  • Mascoma Wealth Management's Exelixis position peaked at $30K in Q4 2017.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.